Lipocalin 2 is essential for chronic kidney disease progression in mice and humans A Viau, K El Karoui, D Laouari, M Burtin, C Nguyen, K Mori, E Pillebout, ... The Journal of clinical investigation 120 (11), 4065-4076, 2010 | 428 | 2010 |
A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy K El Karoui, GS Hill, A Karras, C Jacquot, L Moulonguet, O Kourilsky, ... Journal of the American Society of Nephrology 23 (1), 137-148, 2012 | 161 | 2012 |
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients C Couchoud, F Bayer, C Ayav, C Béchade, P Brunet, F Chantrel, L Frimat, ... Kidney international 98 (6), 1519-1529, 2020 | 139 | 2020 |
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease C Cohen, B Royer, V Javaugue, R Szalat, K El Karoui, A Caulier, ... Kidney International 88 (5), 1135-1143, 2015 | 139 | 2015 |
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies K El Karoui, GS Hill, A Karras, L Moulonguet, V Caudwell, A Loupy, ... Kidney international 79 (6), 643-654, 2011 | 138 | 2011 |
Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2 K El Karoui, A Viau, O Dellis, A Bagattin, C Nguyen, W Baron, M Burtin, ... Nature communications 7 (1), 10330, 2016 | 111 | 2016 |
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment K El Karoui, AS De Vriese Kidney International 101 (5), 883-894, 2022 | 106 | 2022 |
Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies GS Hill, K El Karoui, A Karras, C Mandet, JPD Van Huyen, D Nochy, ... Kidney international 79 (6), 635-642, 2011 | 98 | 2011 |
Renal involvement in Castleman disease K El Karoui, V Vuiblet, D Dion, H Izzedine, J Guitard, L Frimat, ... Nephrology Dialysis Transplantation 26 (2), 599-609, 2011 | 98 | 2011 |
Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome J Zuber, M Frimat, S Caillard, N Kamar, P Gatault, F Petitprez, L Couzi, ... Journal of the American Society of Nephrology 30 (12), 2449-2463, 2019 | 96 | 2019 |
Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients P Attias, H Sakhi, P Rieu, A Soorkia, D Assayag, S Bouhroum, P Nizard, ... Kidney International 99 (6), 1490-1492, 2021 | 92 | 2021 |
The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits M Vignon, C Cohen, S Faguer, LH Noel, C Guilbeau, M Rabant, S Higgins, ... Kidney international 91 (3), 720-728, 2017 | 68 | 2017 |
Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients M Vignon, V Javaugue, MP Alexander, K El-Karoui, A Karras, ... Leukemia 31 (1), 123-129, 2017 | 65 | 2017 |
Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis I Boudhabhay, V Poillerat, A Grunenwald, C Torset, J Leon, MV Daugan, ... Kidney International 99 (3), 581-597, 2021 | 61 | 2021 |
Kinetics of anti–SARS-CoV-2 IgG antibodies in hemodialysis patients six months after infection H Sakhi, D Dahmane, P Attias, T Kofman, M Bouvier, N Lapidus, S Fourati, ... Journal of the American Society of Nephrology 32 (5), 1033-1036, 2021 | 59 | 2021 |
Podocyte injury in lupus nephritis H Sakhi, A Moktefi, K Bouachi, V Audard, C Hénique, P Remy, M Ollero, ... Journal of clinical medicine 8 (9), 1340, 2019 | 57 | 2019 |
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database L Hoisnard, B Lebrun-Vignes, S Maury, M Mahevas, K El Karoui, L Roy, ... Scientific Reports 12 (1), 7140, 2022 | 56 | 2022 |
Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome G Dorval, O Gribouval, V Martinez-Barquero, E Machuca, MJ Tête, ... Pediatric Nephrology 33, 473-483, 2018 | 47 | 2018 |
Posterior reversible encephalopathy syndrome in systemic lupus erythematosus K El Karoui, M Le Quintrec, E Dekeyser, A Servais, A Hummel, F Fadel, ... Nephrology Dialysis Transplantation 23 (2), 757-763, 2008 | 46 | 2008 |
Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome K El Karoui, I Boudhabhay, F Petitprez, P Vieira-Martins, F Fakhouri, ... Haematologica 104 (12), 2501, 2019 | 42 | 2019 |